Acelyrin Inc. - SLRN Earnings per share for the trailing year

Public company logo of Acelyrin Inc. (SLRN)

The year-over-year change in EPS (TTM) complements the data on the implementation of ESG standards and bioethics in the development of Acelyrin, Inc. (SLRN), with the value serving as the baseline metric. High business scalability is ensured by patent protection of formulas coupled with low production costs. Rigorous FDA testing and expensive research create a significant barrier to entry for new players.

acelyrin.com (SLRN): Earnings per share for the last twelve months from 07/04/2022 to 11/15/2026

acelyrin.com - analytical breakdowns and key metrics (SLRN)

- stock price and consensus target price:
Fundamental company valuation:SLRN, Acelyrin Inc.
Mass-produced product of Acelyrin, Inc.

Acelyrin, Inc. (SLRN) minimizes political risks by developing immunological drugs in the US and EU, ensuring the stability of its operating cycle. Year-over-year (TTM) EPS growth measures the dynamics of net income per share, comparing actual GAAP and Non-GAAP results. This metric reveals real profitability by stripping away management's accounting adjustments. Through this, an investor determines the business's margin of safety and the risk of overpaying for the asset. Analyze this chart of YoY TTM earnings per share growth rates to assess the amplitude of profitability fluctuations.

Competitor analysis

Earnings per share for the trailing year HLN (Haleon)|KVUE: Net earnings per share (EPS TTM)|Verona Pharma Corp - Earnings per share for the trailing year|MENS (Jyong Biotech Limited) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ligand.com LGND|Earnings per share for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALVO (Alvotech S.A.)|Liquidia Technologies - Earnings per share for the last twelve months|Galapagos Corp - Net earnings per share (EPS TTM)|ANIP (ANI Pharmaceuticals) - Earnings per share for the last 12 months|MannKind Corp. (MNKD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Net earnings per share (EPS TTM)|SPRY: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TBPH|Net earnings per share for the last four quarters Aquestive Therapeutics, Inc.|Earnings per share for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Earnings per share for the last 12 months|TNXP - Earnings per share for the last twelve months|Net earnings per share for the last four quarters SXT Pharmaceuticals SXTC|EPRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months bioharvest.com (BHST)|Net earnings per share for the last 12 months EXOZ|ORMP: Earnings per share for the trailing year|Earnings per share for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC (ABVC BioPharma, Inc)|Earnings per share for the trailing year CPIX|QNTM - Earnings per share for the last twelve months|FibroGen Corp (FGEN) - Net earnings per share for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Earnings per share for the last twelve months|Rani Therapeutics (RANI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Synergy CHC Corp.|Net earnings per one share for the last twelve months rallybio.com RLYB|Net earnings per share (EPS TTM) LEXX|PULM: Earnings per one share for the last 12 months|Pheton Holdings Ltd - Net earnings per share for the last 12 months|APM - Net earnings per share for the last 12 months|LYRA - Earnings per share for the last twelve months|Earnings per share for the trailing year IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Earnings per share for the last twelve months|cbdMD Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) LIPO|Net earnings per share (EPS TTM) optinose.com (OPTN)|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Net earnings per one share for the last twelve months|PTPI - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Qilian International Corp QLI|TFF Pharma (TFFP) - Earnings per share for the last twelve months